Actively Recruiting
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
Led by Columbia University · Updated on 2025-07-29
418
Participants Needed
1
Research Sites
476 weeks
Total Duration
On this page
Sponsors
C
Columbia University
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study will test two active evidence-based "practice coaching" (PC) interventions to improve opioid treatment programs' (OTPs') provision and sustained implementation of on-site 1) HIV testing and linkage to care and 2) HIV/Hepatitis C virus (HCV) testing and linkage to care among patients seeking/receiving substance use disorder treatment. Aims are: Aim 1: To evaluate the effectiveness of the PC interventions on improving patient uptake of HIV testing in OTPs including the incremental impact of the HIV/HCV intervention on HIV testing. Aim 2: To examine, using mixed-methods, the impact of the PC interventions on the initiation and sustained provision of HIV testing and timely linkage to care. Aim 3: To evaluate the health outcomes, health care utilization, and cost-effectiveness of the PC interventions compared incrementally to one another and to the control condition. Primary Hypothesis: 1. The two PC interventions will result in significantly higher proportions of patients tested for HIV than the information control condition during the "initial impact" period (7-12 months post-randomization or T3), controlling for the proportion of patients tested during the baseline period, T1 (Primary) and during the "sustained impact" period, 13-18 months post-randomization or T4 (Secondary). 2. The HIV/HCV PC intervention will result in significantly higher proportions of patients tested for HIV than the HIV PC intervention during the initial impact period (7-12 months post-randomization or T3), controlling for the proportion of patients tested during the baseline period, T1 (Secondary) and during the "sustained impact" period, 13-18 months post-randomization or T4 (Secondary).
CONDITIONS
Official Title
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Sites must see at least 150 unduplicated patients per year
- Sites must be capable and willing to collect data on patients offered, completed HIV and/or HCV tests, referrals if positive, and linkage to care within 30 days
- Sites must be able and willing to provide patient demographic and testing data, including gender and race/ethnicity categories, and data on test reimbursement
- Key staff at sites must be willing to consent to participate in surveys, interviews, and coaching throughout the study
You will not qualify if you...
- Sites with over 50% of patients tested for HIV or HCV in the prior 6 months are excluded
- Sites terminated by the principal investigator's discretion are excluded
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Columbia University Medical Center
New York, New York, United States, 10032
Actively Recruiting
Research Team
L
Lauren Gooden, PhD
CONTACT
T
Terri Liguori, M.Ed., Ed.S.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here